tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OKUR Stock Latest News

Buy Rating for OnKure Therapeutics Driven by Promising Developments in Metastatic Breast Cancer Treatment and Strong Financial Position
RatingsBuy Rating for OnKure Therapeutics Driven by Promising Developments in Metastatic Breast Cancer Treatment and Strong Financial Position
9d ago
OKUR
OnKure Elects Directors at Annual Stockholder Meeting
PremiumCompany Announcements
OnKure Elects Directors at Annual Stockholder Meeting
15d ago
8K
OKUR
One new option listing and nine option delistings on May 19th
PremiumThe Fly
One new option listing and nine option delistings on May 19th
25d ago
J
DFS
Promising Developments and Positive Trial Results Reinforce Buy Rating for OnKure Therapeutics
PremiumRatings
Promising Developments and Positive Trial Results Reinforce Buy Rating for OnKure Therapeutics
1M ago
OKUR
OnKure Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
OnKure Therapeutics Reports Q1 2025 Progress and Financials
1M ago
OKUR
OnKure Therapeutics reports Q1 EPS ($1.19), consensus ($1.38)
PremiumThe FlyOnKure Therapeutics reports Q1 EPS ($1.19), consensus ($1.38)
1M ago
OKUR
OnKure Therapeutics sees cash runway into 4Q26
Premium
The Fly
OnKure Therapeutics sees cash runway into 4Q26
1M ago
OKUR
OnKure Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
OnKure Therapeutics initiated with an Outperform at Evercore ISI
1M ago
OKUR
OnKure Therapeutics price target lowered to $34 from $40 at H.C. Wainwright
PremiumThe Fly
OnKure Therapeutics price target lowered to $34 from $40 at H.C. Wainwright
3M ago
OKUR
Promising Outlook for OnKure Therapeutics: Strategic Developments and Market Expansion Plans for 2025
PremiumRatings
Promising Outlook for OnKure Therapeutics: Strategic Developments and Market Expansion Plans for 2025
3M ago
OKUR
Oppenheimer biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
3M ago
AZN
LLY
Optimistic Buy Rating for OnKure Therapeutics Driven by Promising OKI-219 Development and Future Prospects
PremiumRatings
Optimistic Buy Rating for OnKure Therapeutics Driven by Promising OKI-219 Development and Future Prospects
3M ago
OKUR
Onkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies
PremiumCompany AnnouncementsOnkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies
3M ago
OKUR
OnKure Therapeutics Reports Progress and Financials
Premium
Company Announcements
OnKure Therapeutics Reports Progress and Financials
3M ago
OKUR
OnKure Therapeutics price target lowered to $30 from $35 at Oppenheimer
Premium
The Fly
OnKure Therapeutics price target lowered to $30 from $35 at Oppenheimer
3M ago
OKUR
OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)
PremiumThe Fly
OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)
3M ago
OKUR
OnKure Therapeutics initiated with a Buy at JonesResearch
PremiumThe Fly
OnKure Therapeutics initiated with a Buy at JonesResearch
5M ago
LLY
OKUR
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
6M ago
LLY
ARVN
OnKure Therapeutics Advances Cancer Drug Trials
PremiumCompany Announcements
OnKure Therapeutics Advances Cancer Drug Trials
6M ago
8K
OKUR
OnKure Therapeutics announces safety, pharmacokinetic data on OKI-219
PremiumThe FlyOnKure Therapeutics announces safety, pharmacokinetic data on OKI-219
6M ago
OKUR
OnKure Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
OnKure Therapeutics initiated with an Outperform at Leerink
6M ago
OKUR
OnKure Therapeutics Reports Strategic Merger and Financial Updates
Premium
Company Announcements
OnKure Therapeutics Reports Strategic Merger and Financial Updates
7M ago
OKUR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >